Academic Journal
Q3Iranian Journal of Blood and Cancer
About Iranian Journal of Blood and Cancer
Iranian Journal of Blood and Cancer is a scholarly journal published by Iranian Pediatric Hematology and Oncology Society. SCImago 2025 lists it in Q3, with an SJR of 0.319 and H-index of 11.
Coverage: 2014-2025. Research categories: Hematology (Q3); Oncology (Q3).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-09-02. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Hemoglobinopathies and Related Disorders; Iron Metabolism and Disorders; Platelet Disorders and Treatments; Acute Lymphoblastic Leukemia research; Acute Myeloid Leukemia Research; Chronic Lymphocytic Leukemia Research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
NLR, PLR, and HPR as novel diagnostic biomarkers for Acute Lymphoblastic Leukemia
Bahareh Moghimian, Ahmad Jafari-joshaghan
2023-06-01 · DOI: 10.58209/ijbc.15.2.80Immunohistochemistry expression of Human Herpes Virus-8 in cutaneous vascular lesions
Saeedeh Khakisahneh, Maryam Hematti
2023-06-01 · DOI: 10.58209/ijbc.15.2.172Remodeling Methods of TIME for Enhanced Immunotherapy against Non-Melanoma Skin Cancer
Arooba Farman Farman
2023-06-01 · DOI: 10.58209/ijbc.15.2.128The dispersion of pediatric cancer biobanks in the Middle East: a global review of available resources
Peyman Eshghi, Nasrin Dehghan-Nayeri
2023-06-01 · DOI: 10.58209/ijbc.15.2.113Guideline for the diagnosis and treatment of hypothyroidism and hypoparathyroidism in patients with blood transfusion-dependent thalassemia
Nahid Hashemi-madani, Neda Rahimian
2023-06-01 · DOI: 10.58209/ijbc.15.2.89Harnessing the Potential of Vesicular Stomatitis Virus as a Novel Therapeutic Strategy for Cancer Treatment
Fatemeh Mousavinasab, Elham Razani
2023-06-01 · DOI: 10.58209/ijbc.15.2.117Plasma industry in Iran: Challenges and opportunities
Mohammad-Javad Sanaei, Hassan Abolghasemi
2023-06-01 · DOI: 10.58209/ijbc.15.2.97Genetics and pathophysiology of severe congenital neutropenias (SCNs)
Samareh Younesian, Amir-Mohammad Yousefi
2023-06-01 · DOI: 10.58209/ijbc.15.2.146Angioimmunoblastic T-cell lymphoma associated with leukocytosis and lymphocytosis; a case report and systematic review
Esmaeil Shahabi Satlsar, Saeid Anvari
2023-03-01 · DOI: 10.58209/ijbc.15.1.36Evaluation the Effect of Chemotherapy Drugs and Thiosemicarbazone Complexes on the Expression of URHC and CASC15 LncRNAs in Acute Lymphoblastic Leukemia Cell Line
Arezoo Hassani, Golnaz Asaadi Tehrani
2023-03-01 · DOI: 10.58209/ijbc.15.1.1Serum visfatin level as a prognostic marker in colorectal cancer patients: A retrospective cohort study
Amir Hooshang Mohammadpour, Kamran Ghaffarzadegan
2023-03-01 · DOI: 10.58209/ijbc.15.1.53A case of Kikuchi–Fujimoto Disease in a SLE patient; potential importance of OR8U8 gene polymorphisms
Ali Gholami, Baharak Tasorian
2023-03-01 · DOI: 10.58209/ijbc.15.1.10The effect of Vitamin E and N-acetyl cysteine on oxidative status and hemoglobin level in transfusion-dependent thalassemia patients: A systematic review and meta-analysis
Sezaneh Haghpanah, Mahnaz Hosseini-Bensenjan
2023-03-01 · DOI: 10.58209/ijbc.15.1.22CRISPR/Cas9 technology: A promising gene-editing tool for the treatment of cancers
Muhammad Khairi Ahmad, Kumitaa Theva Das
2023-03-01 · DOI: 10.58209/ijbc.15.1.60A review of the interaction between the coagulation system and cancer
Najmaldin Saki, Mohammadreza Javan
2023-03-01 · DOI: 10.58209/ijbc.15.1.71Right ventricular thrombus in a child with aluminum phosphide poisoning: A case report and review of the literature
Mehdi Sheibani, Fariba Farnaghi
2023-03-01 · DOI: 10.58209/ijbc.15.1.17The Mitochondrial DNA 4977-bp Deletion in Patients with Colorectal Cancer: a Case-control Study in Iran
Sharareh Kamfar, Fariba Alaei
2022-12-01 · DOI: 10.58209/ijbc.14.4.104“How should we treat older patients with Metastatic Colorectal Cancer, A Review”
Alfredo Colombo, Concetta Maria Porretto
2022-12-01 · DOI: 10.58209/ijbc.14.4.116Blood culture-negative infective endocarditis with thalassemia and neurological complication: A dangerous combination
Novia Kusumawardhani, Ivana Purnama Dewi
2022-12-01 · DOI: 10.58209/ijbc.14.4.111Gold nanoparticles in radiation therapy: an old story yet mesmerizing
Yasamin Kavousi, Mohadeseh Mohammadi Mohammadi
2022-12-01 · DOI: 10.58209/ijbc.14.4.140Reviews
Community Reviews
Version History
October 2, 2026 at 9:57 pm
October 2, 2026